Aussie shares of Immuron jumps on robust FY23 sales
** Shares of Australia's Immuron IMC.AX rise as much as
9.59% to A$0.08
** Biopharmaceutical co says its sales for fiscal 2023 has
increased over 136%
** Adds global sales for fiscal 2023 was A$1.80 mln ($1.20
mln)
** Stock has fallen 15.1% this year as of last close
($1 = 1.4941 Australian dollars)
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million